FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder.
Bakkar AA, Wallerand H, Radvanyi F, Lahaye JB, Pissard S, Lecerf L, Kouyoumdjian JC, Abbou CC, Pairon JC, Jaurand MC, Thiery JP, Chopin DK, de Medina SG.
Bakkar AA, et al. Among authors: wallerand h.
Cancer Res. 2003 Dec 1;63(23):8108-12.
Cancer Res. 2003.
PMID: 14678961